, Tracking Stock Market Picks
Enter Symbol:
Eli Lilly And Company (LLY) [hlAlert]

Sell LLY
down 36.76 %

Eli Lilly And Company (LLY) rated Sell

Posted on: Monday,  Nov 5, 2007  9:25 AM ET by HSBC Securities

HSBC Securities rated Sell Eli Lilly And Company (NYSE: LLY) on 11/05/2007, when the stock price was $52.95.
Since then, Eli Lilly And Company has gained 58.15% as of 12/28/2015's recent price of $83.74.
If you would have followed this HSBC Securities's recommendation on LLY, you would have lost 36.76% of your investment in 2975 days.

Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

HSBC has refined and refocused its Global Equities organisation, creating a lean and flexible business model built to meet the needs of global issuers and investors today and in the future. Acknowledging the changing demands of clients, we have also refined our research model, moving away from traditional maintenance to focus on long term, thematic research (a two-year-plus horizon) combined with short term (zero to three months), real-time, actionable ideas both for companies and sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/5/2007 9:25 AM Sell
as of 8/27/2015
1 Week up  4.11 %
1 Month down  -1.29 %
3 Months down  -14.61 %
1 YTD down  -64.19 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy